Argentus Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-11,828
Closed -$746K 3
2016
Q3
$746K Sell
11,828
-1,430
-11% -$92.6K 0.26% 84
2016
Q2
$821K Sell
13,258
-4,445
-25% -$271K 0.35% 57
2016
Q1
$1.01M Buy
17,703
+1,310
+8% +$73K 0.36% 70
2015
Q4
$971K Sell
16,393
-48,359
-75% -$2.79M 0.3% 80
2015
Q3
$3.52M Sell
64,752
-1,951
-3% -$127K 0.52% 48
2015
Q2
$4.48M Sell
66,703
-339
-0.5% -$22.1K 0.68% 39
2015
Q1
$3.92M Sell
67,042
-465
-0.7% -$28.1K 0.62% 39
2014
Q4
$4.42M Buy
67,507
+19,492
+41% +$1.23M 0.74% 30
2014
Q3
$2.77M Sell
48,015
-395
-0.8% -$21.9K 0.44% 57
2014
Q2
$2.73M Buy
48,410
+2,005
+4% +$105K 0.72% 31
2014
Q1
$2.38M Sell
46,405
-5,581
-11% -$282K 0.58% 27
2013
Q4
$2.75M Buy
51,986
+4,929
+10% +$242K 0.58% 27
2013
Q3
$2.1M Sell
47,057
-4,519
-9% -$200K 0.49% 33
2013
Q2
$2.13M Buy
+51,576
New +$2.26M 0.5% 31

Other funds holding ABBV

Argentus Capital Management's ABBV Position: Q4 2016 in Review

Argentus Capital Management sold out of AbbVie (ABBV) in Q4 2016, closing a stake of 11,828 shares — an estimated $746K sold.

Argentus Capital Management first reported a position in ABBV in Q2 2013 and held it in 14 quarters. The position peaked at $4.48M in Q2 2015. 1,691 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

  • Argentus Capital Management reported no remaining AbbVie position as of Q4 2016 after selling out during the quarter.
  • Argentus Capital Management sold 11,828 AbbVie shares in Q4 2016, an estimated $746K.
  • Argentus Capital Management first reported a position in AbbVie in Q2 2013 and held it in 14 quarters.
  • Argentus Capital Management's AbbVie position peaked at $4.48M in Q2 2015.
  • 1,691 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on Argentus Capital Management's 13F filing for Q4 2016.